A detailed history of Elco Management Co., LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Elco Management Co., LLC holds 6,044 shares of HRMY stock, worth $210,512. This represents 0.13% of its overall portfolio holdings.

Number of Shares
6,044
Holding current value
$210,512
% of portfolio
0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.0 - $39.95 $181,320 - $241,457
6,044 New
6,044 $241,000
Q1 2024

May 14, 2024

BUY
$29.93 - $35.06 $8,350 - $9,781
279 Added 4.18%
6,955 $233,000
Q4 2023

Feb 14, 2024

BUY
$19.2 - $33.78 $128,179 - $225,515
6,676 New
6,676 $215,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.06B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Elco Management Co., LLC Portfolio

Follow Elco Management Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elco Management Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Elco Management Co., LLC with notifications on news.